The BCBS FEP program, which covers federal employees, generally offers the most comprehensive weight loss medication coverage within the BCBS system
In the Step 1 trial (note: funded by Novo-Nordisk) of 1,961 individuals, the average weight loss at 68 weeks was 14.9% at the maximum dose of 2.4 mg weekly, equating to 15.3 kg (33.6 lbs) lost compared to 2.6 kg (5.7 lbs) in the placebo group
Ingredients: Water, L-carnitine base, inulin, acidity regulator (citric acid), green tea extract, sweeteners (sucralose, acesulfame K*), preservatives (potassium sorbate, sodium benzoate), aroma, nicotinamide, calcium pantothenate, pyridoxine HCl, thiamin HCl, dyes (for Cherry flavor: brilliant blue FCF, azorubine** for Apple flavor: quinoline yellow**, brilliant blue FCF)
In conclusion, while semaglutide presents a valuable tool in the management of diabetes and obesity, its potential association with UTIs requires attention and proactive management
The approval process considers developmental factors, metabolic differences, and long-term safety concerns specific to younger populations
68 GLP-1 receptors located in the gastric mucosa regulate insulin secretion but do not affect gastric motility